In March 2026, a team led by Matthew S. Macauley from the University of Alberta published a review in Journal of Biological Chemistry entitled "Writers and readers of sialylation in immunoregulation in cancer." This review systematically summarized the key role of sialylation in tumor immune regulation, focusing on how sialyltransferases, acting as "writers," and Siglec/Selectin, acting […]
About Us
CD BioGlyco is a leading biotechnology company specializing in glycobiology. We deliver high-quality products and services to support cutting-edge research worldwide.
Important Links
Contact Us
